Cue Biopharma (CUE) said late Thursday it priced a public offering of 11.6 million common shares with accompanying warrants to purchase 2.9 million shares at a combined price of $0.50.
The company said it is also offering to certain investors, in lieu of common stock, pre-funded warrants for 12.4 million shares with accompanying warrants for 3.1 million shares at a combined price of $0.499.
The gross proceeds of the offering are expected to be about $12 million.
The offering is anticipated to close around Sept. 30.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments